参考文献/References:
[1]Siegel R,Ma J,Zou Z,et al.Cancer statistics,Cancer statistics, 2014[J].CA Cancer J Clin,2014,64(1):9-29.[2]Liu D,Ding X,Du J,et al.Human NUF2 interacts with centromereassociated protein E and is essential for a stable spindle microtubulekinetochore attachment[J].J Biol Chem,2007,282(29):21415-21424.[3]Jiang X,Jiang Y,Luo S,et al.Correlation of NUF2 Overexpression with Poorer Patient Survival in Multiple Cancers[J].Cancer Res Treat,2021,53(4):944-961.[4]Shan L,Zhu XL,Zhang Y,et al.Expression and clinical significance of NUF2 in kidney renal clear cell carcinoma[J].Transl Androl Urol,2021,10(9):3628-3637.[5]Chen W,Zheng R,Baade PD,et al.Cancer statistics in China, 2015[J].CA Cancer J Clin,2016,66(2):115-132.[6]Posadas EM,Figlin RA.Systemic therapy in renal cell carcinoma: advancing paradigms[J].Oncology (Williston Park),2012,26(3):290-301.[7]Sansregret L,Vanhaesebroeck B,Swanton C.Determinants and clinical implications of chromosomal instability in cancer[J].Nat Rev Clin Oncol,2018,15(3):139-151.[8]Obara W,Sato F,Takeda K,et al.Phase I clinical trial of cell division associated 1 (CDCA1) peptide vaccination for castration resistant prostate cancer[J].Cancer Sci,2017,108(7):1452-1457.[9]孙景波,陈嘉炜,王植治,等.NUF2基因在乳腺癌中的表达及临床意义[J].南方医科大学学报,2019,39(5):591-597.[10]Hu P,Chen X,Sun J,et al.siRNA-mediated knockdown against NUF2 suppresses pancreatic cancer proliferation in vitro and in vivo[J].Biosci Rep,2015;35(1):79-86.[11]Huang SK,Qian JX,Yuan BQ,et al.SiRNA-mediated knockdown against NUF2 suppresses tumor growth and induces cell apoptosis in human glioma cells[J].Cell Mol Biol,2014,60(4):30-36.[12]Liu Q,Dai SJ,Li H,et al.Silencing of NUF2 inhibits tumor growth and induces apoptosis in human hepatocellular carcinomas[J].Asian Pac J Cancer Prev,2014,15(20):8623-8629.[13]Chen M,Li S,Liang Y,et al.Integrative Multi-Omics Analysis of Identified NUF2 as a Candidate Oncogene Correlates With Poor Prognosis and Immune Infiltration in Non-Small Cell Lung Cancer[J].Front Oncol,2021,11:656509.[14]Shi L,Shang X,Nie K,et al.Identification of potential crucial genes associated with the pathogenesis and prognosis of liver hepatocellular carcinoma[J].J Clin Pathol,2021,74(8):504-512.[15]Zhang H,Zou J,Yin Y,et al.Bioinformatic analysis identifies potentially key differentially expressed genes in oncogenesis and progression of clear cell renal cell carcinoma[J].Peer J,2019,7:e8096.[16]Torti SV,Manz DH,Paul BT,et al.Iron and Cancer[J].Annu Rev Nutr,2018,21(38):97-125.[17]Greene CJ,Attwood K,Sharma NJ,et al.Transferrin receptor 1 upregulation in primary tumor and downregulation in benign kidney is associated with progression and mortality in renal cell carcinoma patients[J].Oncotarget,2017,8(63):107052-107075.[18]Wang F,Liu A,Bai R,et al.Hepcidin and iron metabolism in the pathogenesis of prostate cancer[J].J BUON,2017,22(5):1328-1332.[19]Sornjai W,Nguyen Van Long F,Pion N,et al.Iron and hepcidin mediate human colorectal cancer cell growth[J].Chem Biol Interact,2020,1(319):109021.[20]Zhang D,Wang Y,Hu X.Identification and Comprehensive Validation of a DNA Methylation-Driven Gene-Based Prognostic Model for Clear Cell Renal Cell Carcinoma[J].DNA Cell Biol,2020,39(10):1799-1812.[21]Wan B,Liu B,Huang Y,et al.Prognostic value of immune-related genes in clear cell renal cell carcinoma[J].Aging (Albany NY),2019,11(23):11474-11489.[22]Wu Y,Wei X,Feng H,et al.An eleven metabolic gene signature-based prognostic model for clear cell renal cell carcinoma[J].Aging (Albany NY),2020,12(22):23165-23186.[23]Guo L,Wang Z,Du Y,et al.Random-forest algorithm based biomarkers in predicting prognosis in the patients with hepatocellular carcinoma[J].Cancer Cell Int,2020,20:251.